AI Article Synopsis

  • The study aimed to assess how microbubble size and ultrasonic parameters affect the effectiveness of sonothrombolysis, a process that uses ultrasound to dissolve blood clots.
  • Experiments showed that larger microbubbles (3 μm) were more effective at 1 MHz, while smaller ones (1 μm) worked better at 3 MHz; however, smaller bubbles were more likely to be destroyed, impacting efficacy.
  • Controlling microbubble characteristics allows for the optimization of ultrasound settings, achieving effective sonothrombolysis with lower power levels, which could enhance safety in medical applications.

Article Abstract

Purpose: To quantify the effects of microbubble (MB) size, elasticity, and pulsed ultrasonic parameters on in vitro sonothrombolysis (ultrasound [US]-mediated thrombolysis) efficacy.

Materials And Methods: Monodispersive MBs with diameters of 1 μm or 3 μm were exposed to pulsed US (1 MHz or 3 MHz) to lyse rabbit blood clots. Sonothrombolysis efficacy (clot mass loss) was measured as functions of MB size and concentration, ultrasonic frequency and intensity, pulse duration (PD), pulse repeat frequency (PRF), and duty factor.

Results: Sonothrombolysis at 1 MHz was more effective using 3-μm MBs and at 3 MHz using 1-μm MBs. Sonothrombolysis was more effective at 1 MHz when≥75% of MBs remained intact, especially for 3-μm MBs; improving sonothrombolysis by increasing PRF from 100 Hz to 400 Hz at 3 MHz was associated with increasing 3-μm MB survival. However, 60% of 1-μm MBs were destroyed during maximal sonothrombolysis at 3 MHz, indicating that considerable MB collapse may be required for sonothrombolysis under these conditions.

Conclusions: The ability to control MB size and elasticity permits using a wide range of US parameters (eg, frequency, intensity) to produce desired levels of sonothrombolysis. Comparable, maximal sonothrombolysis efficacy was achieved at 20-fold lower intensity with 3-μm MBs (0.1W/cm(2)) than with 1-μm MBs (2.0W/cm(2)), a potential safety issue for in vivo sonothrombolysis. US parameters that maximized MB survival yielded maximal sonothrombolysis efficacy except with 1-μm MBs at 3MHz where most MBs were destroyed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508303PMC
http://dx.doi.org/10.1016/j.jvir.2012.08.019DOI Listing

Publication Analysis

Top Keywords

sonothrombolysis efficacy
16
1-μm mbs
16
sonothrombolysis
12
3-μm mbs
12
maximal sonothrombolysis
12
mbs
10
ultrasonic parameters
8
parameters vitro
8
vitro sonothrombolysis
8
size elasticity
8

Similar Publications

Sonothrombolysis Using Microfluidically Produced Microbubbles in a Murine Model of Deep Vein Thrombosis.

Ann Biomed Eng

September 2024

Department of Biomedical Engineering, University of Virginia, 415 Lane Road, Charlottesville, VA, 22908, USA.

Article Synopsis
  • Research is focused on finding safe alternatives for treating deep vein thrombosis (DVT) due to risks from traditional anticoagulants and thrombolytics.
  • Sonothrombolysis, which uses microbubbles and ultrasound along with thrombolytic agents, is being investigated to enhance the breakdown of blood clots.
  • In a study with mice, sonothrombolysis significantly reduced DVT volume from 52% to 20% after therapy, indicating its potential effectiveness in treating venous thromboembolism.
View Article and Find Full Text PDF

Enhancing sonothrombolysis outcomes with dual-frequency ultrasound: Insights from an in silico microbubble dynamics study.

Comput Biol Med

October 2024

School of Engineering and Information Technology, Faculty of Science and Technology, Federation University, VIC 3350, Australia.

Sonothrombolysis is a technique that employs the ultrasound waves to break down the clot. Recent studies have demonstrated significant improvement in the treatment efficacy when combining two ultrasound waves of different frequencies. Nevertheless, the findings remain conflicted on the ideal frequency pairing that leads to an optimal treatment outcome.

View Article and Find Full Text PDF

Background: Despite advances in timely revascularisation of ST elevation myocardial infarction (STEMI) patients, there are several practical and unavoidable delays. Sonothrombolysis (administered during micro boluses of Perfluoropropane) initiated bedside as a point-of-care therapy during the initial evaluation of the patient may potentially mitigate this by producing early culprit vessel revascularisation.

Methods: This was a prospective, single-centre study on hemodynamically stable patients presenting within 12 hours of a first STEMI who consented for study participation.

View Article and Find Full Text PDF

Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial.

Am Heart J

September 2024

Faculty of Medicine and Health, Charles Perkins Centre Nepean, Sydney Medical School Nepean, The University of Sydney, New South Wales, Australia; Department of Cardiology, Nepean Hospital, Sydney, New South Wales, Australia. Electronic address:

Objectives: This study aims to evaluate the efficacy and cost-effectiveness of sonothrombolysis delivered pre and post primary percutaneous coronary intervention (pPCI) on infarct size assessed by cardiac MRI, in patients presenting with STEMI, when compared against sham procedure.

Background: More than a half of patients with successful pPCI have significant microvascular obstruction and residual infarction. Sonothrombolysis is a therapeutic use of ultrasound with contrast enhancement that may improve microcirculation and infarct size.

View Article and Find Full Text PDF
Article Synopsis
  • Sonophoresis is a transdermal drug delivery method that uses low-frequency ultrasound to help penetrate drug molecules into the skin, serving as an alternative to oral and injection methods.
  • The mechanism mainly relies on cavitation, which involves creating and bursting gaseous bubbles, along with other effects like thermal, convectional, and mechanical influences.
  • Applications of sonophoresis include transporting hydrophilic drugs, gene and vaccine delivery, and it can be augmented with other techniques like chemical enhancers and microneedles for improved drug absorption, though more research is needed to fully understand its mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!